GBC-003
Influenza and emerging viral infections (mRNA vaccine)
Phase 1/2Active
Key Facts
Indication
Influenza and emerging viral infections (mRNA vaccine)
Phase
Phase 1/2
Status
Active
About General Biologicals Corporation
Taiwan’s fast‑growing CDMO delivering end‑to‑end biologics manufacturing for oncology and immunology.
View full company profile